Physician profile
Hazim Al Ameri
NPI 1508065848
$6,476.38
in general payments reported to CMS, 2019-2025
17 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,576 · 2020: $37.76 · 2021: $1,047 · 2022: $78.26 · 2023: $122 · 2024: $1,160 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $901 · Travel and Lodging: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $900.92 |
| Travel and Lodging | $836.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,764.91 | 2019-2025 | |
| Medical Device Business Services, INC. | $1,110.99 | 2019-2024 | Carto 3 |
| Abbott Laboratories | $857.34 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $514.85 | 2019-2022 | |
| Biosense Webster, INC. | $288.07 | 2024-2025 | Carto 3 |
| Boston Scientific Corporation | $238.96 | 2019-2025 | Farapulse, General - Therapies, General - Brady |
| Medtronic, INC. | $191.55 | 2021-2025 | Micra |
| Glaxosmithkline, LLC. | $185.63 | 2023-2024 | Arexvy, Nucala |
| Kestra Medical Technology Services, INC. | $114.31 | 2022-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.72 | 2019-2024 | Lifevest |
| Cordis US Corp. | $38.48 | 2024-2025 | Mynx Control Venous, Mynx Venous Vcd |
| Abiomed | $30.80 | 2025 | |
| Medtronic Vascular, INC. | $26.62 | 2020 | |
| Altathera Pharmaceuticals LLC | $25.76 | 2025 | Sotalol Hydrochloride |
| Regeneron Healthcare Solutions, INC. | $14.36 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $13.89 | 2022 | |
| Zoll Circulation INC | $11.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hazim Al Ameri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.